XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock Outstanding [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2021 0 16,878,220        
Balance at Dec. 31, 2021 $ 0 $ 16,878 $ 147,619 $ 264,824 $ (1,546) $ 427,775
Net income 0 0 0 20,728 0 20,728
Other comprehensive loss 0 0 0 0 (10,114) (10,114)
Common dividends declared 0 0 0 (9,053) 0 (9,053)
Equity-based compensation expense 0 25 328 0 0 353
Common stock options exercised $ 0 $ 5 98 0 0 103
Issuance of common stock to 401(k) plan (in shares) 0 9,758        
Issuance of common stock to 401(k) plan $ 0 $ 10 279 0 0 289
Repurchase of common shares (in shares) 0 (415,507)        
Repurchase of common shares $ 0 $ (416) (11,619) 0 0 (12,035)
Other comprehensive loss $ 0 $ 0 0 0 (10,114) (10,114)
Equity-based compensation expense (in shares) 0 25,137        
Repurchase of common shares (in shares) (0) 415,507        
Common stock options exercised (in shares) 0 4,536        
Balance (in shares) at Jun. 30, 2022 0 16,502,144        
Balance at Jun. 30, 2022 $ 0 $ 16,502 136,705 276,499 (11,660) 418,046
Balance (in shares) at Mar. 31, 2022 0 16,781,975        
Balance at Mar. 31, 2022 $ 0 $ 16,782 144,088 269,798 (6,512) 424,156
Net income 0 0 0 11,213 0 11,213
Other comprehensive loss 0 0 0 0 (5,148) (5,148)
Common dividends declared 0 0 0 (4,512) 0 (4,512)
Equity-based compensation expense 0 0 0 0 0 0
Common stock options exercised $ 0 $ 0 181 0 0 181
Issuance of common stock to 401(k) plan (in shares) 0 3,676        
Issuance of common stock to 401(k) plan $ 0 $ 4 100 0 0 104
Repurchase of common shares (in shares) 0 (283,507)        
Repurchase of common shares $ 0 $ (284) (7,664) 0 0 (7,948)
Other comprehensive loss $ 0 $ 0 0 0 (5,148) (5,148)
Repurchase of common shares (in shares) (0) 283,507        
Balance (in shares) at Jun. 30, 2022 0 16,502,144        
Balance at Jun. 30, 2022 $ 0 $ 16,502 136,705 276,499 (11,660) 418,046
Balance (in shares) at Dec. 31, 2022 0 16,225,399        
Balance at Dec. 31, 2022 $ 0 $ 16,225 128,508 292,971 (15,719) 421,985 [1]
Net income 0 0 0 21,596 0 21,596
Other comprehensive loss 0 0 0 0 1,258 1,258
Common dividends declared 0 0 0 (10,272) 0 (10,272)
Equity-based compensation expense 0 24 408 0 0 432
Common stock options exercised $ 0 $ 2 46 0 0 48
Issuance of common stock to 401(k) plan (in shares) 0 262        
Issuance of common stock to 401(k) plan $ 0 $ 0 8 0 0 8
Repurchase of common shares (in shares) 0 279,567        
Repurchase of common shares $ 0 $ (279) (7,410) 0 0 (7,689)
Surrey acquisition (in shares) 0 2,996,786        
Surrey acquisition $ 0 $ 2,997 68,357 0 0 71,354
Other comprehensive loss $ 0 $ 0 0 0 1,258 1,258
Equity-based compensation expense (in shares) 0 24,243        
Repurchase of common shares (in shares) 0 (279,567)        
Common stock options exercised (in shares) 0 2,158        
Balance (in shares) at Jun. 30, 2023 0 18,969,281        
Balance at Jun. 30, 2023 $ 0 $ 18,969 189,917 304,295 (14,461) 498,720
Balance (in shares) at Mar. 31, 2023 0 16,243,551        
Balance at Mar. 31, 2023 $ 0 $ 16,243 128,666 300,047 (13,225) 431,731
Net income 0 0 0 9,814 0 9,814
Other comprehensive loss 0 0 0 0 (1,236) (1,236)
Common dividends declared 0 0 0 (5,566) 0 (5,566)
Equity-based compensation expense $ 0 $ 9 304 0 0 313
Repurchase of common shares (in shares) 0 279,567        
Repurchase of common shares $ 0 $ (280) (7,410) 0 0 (7,690)
Surrey acquisition (in shares) 0 2,996,786        
Surrey acquisition $ 0 $ 2,997 68,357 0 0 71,354
Other comprehensive loss $ 0 $ 0 0 0 (1,236) (1,236)
Equity-based compensation expense (in shares) 0 8,511        
Repurchase of common shares (in shares) 0 (279,567)        
Balance (in shares) at Jun. 30, 2023 0 18,969,281        
Balance at Jun. 30, 2023 $ 0 $ 18,969 $ 189,917 $ 304,295 $ (14,461) $ 498,720
[1] Derived from audited financial statements